Zhitong Finance App News, Rundu Co., Ltd. (002923.SZ) issued an announcement. The company recently received the “Notice of Approval of the Marketing Application for Chemical Ingredients” on lanthanum carbonate issued by the State Drug Administration. Lanthanum carbonate chewable tablets are used to treat hyperphosphatemia in patients with chronic renal failure on hemodialysis or continuous non-bed peritoneal dialysis. This time, we have received an approval notice for the marketing application of lanthanum carbonate raw materials, expanding the company's product matrix in the field of chronic disease treatment and in line with the company's development strategy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.